Di-aspirin derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9351980
APP PUB NO 20130035317A1
SERIAL NO

13578934

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of di-aspirin (bis(2-carboxyphenyl)succinate) and its derivatives in the treatment of colon and colorectal cancer. It also relates to novel derivatives of di-aspirin and to a method of synthesis of the di-aspirin and its derivatives.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERISTY OF WOLVERHAMPTONWULFRUNA STREET WOLVERHAMPTON WEST MIDLANDS WV1 1LY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nicholl, Iain Douglas West Midlands, GB 1 0
Perry, Christopher John West Midlands, GB 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00